Sign in to edit your profile (add interests, mentoring, photo, etc.)

    Parkash Singh Gill, MD

    TitleProfessor of Medicine
    SchoolKeck School of Medicine of USC
    DepartmentMedicine
    AddressNOR 6332
    Health Sciences Campus
    Los Angeles California 90089-9172
    Phone+1 323 865 3909
      Other Positions
      TitleRenette and Marshall Ezralow Family Chair in Cancer Therapeutics


       Overview 
       Overview
      Dr. Gill's primary research interest is in studying novel targets that are expressed both in tumor blood vessels as well as the tumor cell. He has demonstrated the ability to identify and validate novel targets, develop novel target therapeutics and collaborate with clinical investigators to conduct early stage clinical trials.

      Dr. Gill has a strong history of clinical investigations and drug development. His clinical investigations led to the approval of three cancer drugs by the FDA. He also served on the advisory panel for the FDA advisory committee on biologics. Over the past several years his work has focused on the identification of novel cancer and cancer blood vessel targets, validation of the targets in various model systems including genetic mouse models.


       ORNG Applications 
       Featured Videos
       In The News

       Bibliographic 
       Publications
      Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
      List All   |   Timeline
      1. Liang M, Adisetiyo H, Li X, Liu R, Gill P, Roy-Burman P, Jones JO, Mulholland DJ. Correction: Identification of Androgen Receptor Splice Variants in the Pten Deficient Murine Prostate Cancer Model. PLoS One. 2016; 11(3):e0152243..
        View in: PubMed
      2. Wu X, Zahari MS, Ma B, Liu R, Renuse S, Sahasrabuddhe NA, Chen L, Chaerkady R, Kim MS, Zhong J, Jelinek C, Barbhuiya MA, Leal-Rojas P, Yang Y, Kashyap MK, Marimuthu A, Ling M, Fackler MJ, Merino V, Zhang Z, Zahnow CA, Gabrielson E, Stearns V, Roa JC, Sukumar S, Gill PS, Pandey A. Global phosphotyrosine survey in triple-negative breast cancer reveals activation of multiple tyrosine kinase signaling pathways. Oncotarget. 2015 Oct 6; 6(30):29143-60..
        View in: PubMed
      3. Zhou B, Wang H, Liu R, Wang M, Deng H, Giglio BC, Gill PS, Shan H, Li Z. PET Imaging of Dll4 Expression in Glioblastoma and Colorectal Cancer Xenografts Using (64)Cu-Labeled Monoclonal Antibody 61B. Mol Pharm. 2015 Oct 5; 12(10):3527-34..
        View in: PubMed
      4. Pan CX, Zhang H, Tepper CG, Lin TY, Davis RR, Keck J, Ghosh PM, Gill P, Airhart S, Bult C, Gandara DR, Liu E, de Vere White RW. Development and Characterization of Bladder Cancer Patient-Derived Xenografts for Molecularly Guided Targeted Therapy. PLoS One. 2015; 10(8):e0134346..
        View in: PubMed
      5. Liang M, Adisetiyo H, Liu X, Liu R, Gill P, Roy-Burman P, Jones JO, Mulholland DJ. Identification of Androgen Receptor Splice Variants in the Pten Deficient Murine Prostate Cancer Model. PLoS One. 2015; 10(7):e0131232..
        View in: PubMed
      6. Yu H, Liu R, Ma B, Li X, Yen HY, Zhou Y, Krasnoperov V, Xia Z, Zhang X, Bove AM, Buscarini M, Parekh D, Gill IS, Liao Q, Tretiakova M, Quinn D, Zhao J, Gill PS. Axl receptor tyrosine kinase is a potential therapeutic target in renal cell carcinoma. Br J Cancer. 2015 Aug 11; 113(4):616-25..
        View in: PubMed
      7. Ferguson BD, Carol Tan YH, Kanteti RS, Liu R, Gayed MJ, Vokes EE, Ferguson MK, John Iafrate A, Gill PS, Salgia R. Novel EPHB4 Receptor Tyrosine Kinase Mutations and Kinomic Pathway Analysis in Lung Cancer. Sci Rep. 2015; 5:10641..
        View in: PubMed
      8. Wang H, Li D, Liu S, Liu R, Yuan H, Krasnoperov V, Shan H, Conti PS, Gill PS, Li Z. Small-Animal PET Imaging of Pancreatic Cancer Xenografts Using a 64Cu-Labeled Monoclonal Antibody, MAb159. J Nucl Med. 2015 Jun; 56(6):908-13..
        View in: PubMed
      9. Brand TM, Iida M, Stein AP, Corrigan KL, Braverman CM, Coan JP, Pearson HE, Bahrar H, Fowler TL, Bednarz BP, Saha S, Yang D, Gill PS, Lingen MW, Saloura V, Villaflor VM, Salgia R, Kimple RJ, Wheeler DL. AXL Is a Logical Molecular Target in Head and Neck Squamous Cell Carcinoma. Clin Cancer Res. 2015 Jun 1; 21(11):2601-12..
        View in: PubMed
      10. Lin YG, Shen J, Yoo E, Liu R, Yen HY, Mehta A, Rajaei A, Yang W, Mhawech-Fauceglia P, DeMayo FJ, Lydon J, Gill P, Lee AS. Targeting the glucose-regulated protein-78 abrogates Pten-null driven AKT activation and endometrioid tumorigenesis. Oncogene. 2015 Feb 16..
        View in: PubMed
      11. Parker B, Marra G, Johnson LA, Margolis HS, Webster SA, Wright L, Lea SN, Gill P, Bayvel P. Transportable cavity-stabilized laser system for optical carrier frequency transmission experiments. Appl Opt. 2014 Dec 10; 53(35):8157-66..
        View in: PubMed
      12. Ferguson BD, Tretiakova MS, Lingen MW, Gill PS, Salgia R. Expression of the EPHB4 receptor tyrosine kinase in head and neck and renal malignancies - implications for solid tumors and potential for therapeutic inhibition. Growth Factors. 2014 Dec; 32(6):202-6..
        View in: PubMed
      13. Li X, Choi WW, Yan R, Yu H, Krasnoperov V, Kumar SR, Schuckman A, Klumpp DJ, Pan CX, Quinn D, Gill IS, Gill PS, Liu R. The Differential Expression of EphB2 and EphB4 Receptor Kinases in Normal Bladder and in Transitional Cell Carcinoma of the Bladder. PLoS One. 2014; 9(8):e105326..
        View in: PubMed
      14. Brand TM, Iida M, Stein AP, Corrigan KL, Braverman CM, Luthar N, Toulany M, Gill PS, Salgia R, Kimple RJ, Wheeler DL. AXL Mediates Resistance to Cetuximab Therapy. Cancer Res. 2014 Sep 15; 74(18):5152-64..
        View in: PubMed
      15. Li D, Liu S, Liu R, Park R, Yu H, Krasnoperov V, Gill PS, Li Z, Shan H, Conti PS. Axl-Targeted Cancer Imaging with Humanized Antibody h173. Mol Imaging Biol. 2014 Aug; 16(4):511-8..
        View in: PubMed
      16. Liu S, Li D, Guo J, Canale N, Li X, Liu R, Krasnoperov V, Gill PS, Conti PS, Shan H, Li Z. Design, Synthesis, and Validation of Axl-Targeted Monoclonal Antibody Probe for microPET Imaging in Human Lung Cancer Xenograft. Mol Pharm. 2014 Nov 3; 11(11):3974-9..
        View in: PubMed
      17. Li D, Liu S, Liu R, Zhou Y, Park R, Naga K, Krasnoperov V, Gill PS, Li Z, Shan H, Conti PS. EphB4-Targeted Imaging with Antibody h131, h131-F(ab')2 and h131-Fab. Mol Pharm. 2013 Dec 2; 10(12):4527-33..
        View in: PubMed
      18. Prieto L, Haned H, Mosquera A, Crespillo M, Alemañ M, Aler M, Alvarez F, Baeza-Richer C, Dominguez A, Doutremepuich C, Farfán MJ, Fenger-Grøn M, García-Ganivet JM, González-Moya E, Hombreiro L, Lareu MV, Martínez-Jarreta B, Merigioli S, Milans Del Bosch P, Morling N, Muñoz-Nieto M, Ortega-González E, Pedrosa S, Pérez R, Solís C, Yurrebaso I, Gill P. Euroforgen-NoE collaborative exercise on LRmix to demonstrate standardization of the interpretation of complex DNA profiles. Forensic Sci Int Genet. 2014 Mar; 9:47-54..
        View in: PubMed
      19. Liu R, Li X, Gao W, Zhou Y, Wey S, Mitra SK, Krasnoperov V, Dong D, Liu S, Li D, Zhu G, Louie S, Conti PS, Li Z, Lee AS, Gill PS. Monoclonal Antibody against Cell Surface GRP78 as a Novel Agent in Suppressing PI3K/AKT Signaling, Tumor Growth, and Metastasis. Clin Cancer Res. 2013 Dec 15; 19(24):6802-11..
        View in: PubMed
      20. Ferguson BD, Liu R, Rolle CE, Tan YH, Krasnoperov V, Kanteti R, Tretiakova MS, Cervantes GM, Hasina R, Hseu RD, Iafrate AJ, Karrison T, Ferguson MK, Husain AN, Faoro L, Vokes EE, Gill PS, Salgia R. The EphB4 receptor tyrosine kinase promotes lung cancer growth: a potential novel therapeutic target. PLoS One. 2013; 8(7):e67668..
        View in: PubMed
      21. Liu R, Ferguson BD, Zhou Y, Naga K, Salgia R, Gill PS, Krasnoperov V. EphB4 as a therapeutic target in mesothelioma. BMC Cancer. 2013; 13:269..
        View in: PubMed
      22. Liu S, Li D, Park R, Liu R, Xia Z, Guo J, Krasnoperov V, Gill PS, Li Z, Shan H, Conti PS. PET imaging of colorectal and breast cancer by targeting EphB4 receptor with 64Cu-labeled hAb47 and hAb131 antibodies. J Nucl Med. 2013 Jul; 54(7):1094-100..
        View in: PubMed
      23. Li D, Liu S, Liu R, Park R, Hughes L, Krasnoperov V, Gill PS, Li Z, Shan H, Conti PS. Targeting the EphB4 receptor for cancer diagnosis and therapy monitoring. Mol Pharm. 2013 Jan 7; 10(1):329-36..
        View in: PubMed
      24. Hasina R, Mollberg N, Kawada I, Mutreja K, Kanade G, Yala S, Surati M, Liu R, Li X, Zhou Y, Ferguson BD, Nallasura V, Cohen KS, Hyjek E, Mueller J, Kanteti R, El Hashani E, Kane D, Shimada Y, Lingen MW, Husain AN, Posner MC, Waxman I, Villaflor VM, Ferguson MK, Varticovski L, Vokes EE, Gill P, Salgia R. Critical role for the receptor tyrosine kinase EPHB4 in esophageal cancers. Cancer Res. 2013 Jan 1; 73(1):184-94..
        View in: PubMed
      25. Gill P, Gusmão L, Haned H, Mayr WR, Morling N, Parson W, Prieto L, Prinz M, Schneider H, Schneider PM, Weir BS. DNA commission of the International Society of Forensic Genetics: Recommendations on the evaluation of STR typing results that may include drop-out and/or drop-in using probabilistic methods. Forensic Sci Int Genet. 2012 Dec; 6(6):679-88..
        View in: PubMed
      26. Welch LA, Gill P, Phillips C, Ansell R, Morling N, Parson W, Palo JU, Bastisch I. European Network of Forensic Science Institutes (ENFSI): Evaluation of new commercial STR multiplexes that include the European Standard Set (ESS) of markers. Forensic Sci Int Genet. 2012 Dec; 6(6):819-26..
        View in: PubMed
      27. He M, Zhang W, Bakken T, Schutten M, Toth Z, Jung JU, Gill P, Cannon M, Gao SJ. Cancer Angiogenesis Induced by Kaposi Sarcoma-Associated Herpesvirus Is Mediated by EZH2. Cancer Res. 2012 Jul 15; 72(14):3582-92..
        View in: PubMed
      28. Shi S, Liu J, Joshi SB, Krasnoperov V, Gill P, Middaugh CR, Volkin DB. Biophysical characterization and stabilization of the recombinant albumin fusion protein sEphB4-HSA. J Pharm Sci. 2012 Jun; 101(6):1969-84..
        View in: PubMed
      29. Trindade A, Djokovic D, Gigante J, Badenes M, Pedrosa AR, Fernandes AC, Lopes-da-Costa L, Krasnoperov V, Liu R, Gill PS, Duarte A. Low-dosage inhibition of dll4 signaling promotes wound healing by inducing functional neo-angiogenesis. PLoS One. 2012; 7(1):e29863..
        View in: PubMed
      30. Liu R, Trindade A, Sun Z, Kumar R, Weaver FA, Krasnoperov V, Naga K, Duarte A, Gill PS. Inhibition of Notch signaling by Dll4-Fc promotes reperfusion of acutely ischemic tissues. Biochem Biophys Res Commun. 2012 Feb 3; 418(1):173-9..
        View in: PubMed
      31. Freire-Aradas A, Fondevila M, Kriegel AK, Phillips C, Gill P, Prieto L, Schneider PM, Carracedo A, Lareu MV. A new SNP assay for identification of highly degraded human DNA. Forensic Sci Int Genet. 2012 May; 6(3):341-9..
        View in: PubMed
      32. Phillips C, Ballard D, Gill P, Court DS, Carracedo A, Lareu MV. The recombination landscape around forensic STRs: Accurate measurement of genetic distances between syntenic STR pairs using HapMap high density SNP data. Forensic Sci Int Genet. 2012 May; 6(3):354-65..
        View in: PubMed
      33. Patel SR, Bellary S, Qin L, Gill PS, Taheri S, Heitmar R, Gibson JM, Gherghel D. Abnormal retinal vascular function and lipid levels in a sample of healthy UK South Asians. Br J Ophthalmol. 2011 Nov; 95(11):1573-6..
        View in: PubMed
      34. Djokovic D, Trindade A, Gigante J, Badenes M, Silva L, Liu R, Li X, Gong M, Krasnoperov V, Gill PS, Duarte A. Combination of Dll4/Notch and Ephrin-B2/EphB4 targeted therapy is highly effective in disrupting tumor angiogenesis. BMC Cancer. 2010; 10:641..
        View in: PubMed
      35. Ahmad A, Groshong JS, Matta H, Schamus S, Punj V, Robinson LJ, Gill PS, Chaudhary PM. Kaposi sarcoma-associated herpesvirus-encoded viral FLICE inhibitory protein (vFLIP) K13 cooperates with Myc to promote lymphoma in mice. Cancer Biol Ther. 2010 Nov; 10(10):1033-40..
        View in: PubMed
      36. Bennett PC, Gill PS, Silverman S, Blann AD, Lip GY. Ethnic differences in common carotid intima-media thickness, and the relationship to cardiovascular risk factors and peripheral arterial disease: the Ethnic-Echocardiographic Heart of England Screening Study. QJM. 2011 Mar; 104(3):245-54..
        View in: PubMed
      37. Brar M, Cheng L, Yuson R, Mojana F, Freeman WR, Gill PS. Ocular safety profile and intraocular pharmacokinetics of an antagonist of EphB4/EphrinB2 signalling. Br J Ophthalmol. 2010 Dec; 94(12):1668-73..
        View in: PubMed
      38. Lee HR, Lee S, Chaudhary PM, Gill P, Jung JU. Immune evasion by Kaposi's sarcoma-associated herpesvirus. Future Microbiol. 2010 Sep; 5(9):1349-65..
        View in: PubMed
      39. Spannuth WA, Mangala LS, Stone RL, Carroll AR, Nishimura M, Shahzad MM, Lee SJ, Moreno-Smith M, Nick AM, Liu R, Jennings NB, Lin YG, Merritt WM, Coleman RL, Vivas-Mejia PE, Zhou Y, Krasnoperov V, Lopez-Berestein G, Gill PS, Sood AK. Converging evidence for efficacy from parallel EphB4-targeted approaches in ovarian carcinoma. Mol Cancer Ther. 2010 Aug; 9(8):2377-88..
        View in: PubMed
      40. Liu R, Gong M, Li X, Zhou Y, Gao W, Tulpule A, Chaudhary PM, Jung J, Gill PS. Induction, regulation, and biologic function of Axl receptor tyrosine kinase in Kaposi sarcoma. Blood. 2010 Jul 15; 116(2):297-305..
        View in: PubMed
      41. Zhang Y, Liu R, Ni M, Gill P, Lee AS. Cell surface relocalization of the endoplasmic reticulum chaperone and unfolded protein response regulator GRP78/BiP. J Biol Chem. 2010 May 14; 285(20):15065-75..
        View in: PubMed
      42. Krasnoperov V, Kumar SR, Ley E, Li X, Scehnet J, Liu R, Zozulya S, Gill PS. Novel EphB4 monoclonal antibodies modulate angiogenesis and inhibit tumor growth. Am J Pathol. 2010 Apr; 176(4):2029-38..
        View in: PubMed
      43. Liu R, Li X, Tulpule A, Zhou Y, Scehnet JS, Zhang S, Lee JS, Chaudhary PM, Jung J, Gill PS. KSHV-induced notch components render endothelial and mural cell characteristics and cell survival. Blood. 2010 Jan 28; 115(4):887-95..
        View in: PubMed
      44. He S, Kumar SR, Zhou P, Krasnoperov V, Ryan SJ, Gill PS, Hinton DR. Soluble EphB4 inhibition of PDGF-induced RPE migration in vitro. Invest Ophthalmol Vis Sci. 2010 Jan; 51(1):543-52..
        View in: PubMed
      45. Kumar SR, Scehnet JS, Ley EJ, Singh J, Krasnoperov V, Liu R, Manchanda PK, Ladner RD, Hawes D, Weaver FA, Beart RW, Singh G, Nguyen C, Kahn M, Gill PS. Preferential induction of EphB4 over EphB2 and its implication in colorectal cancer progression. Cancer Res. 2009 May 1; 69(9):3736-45..
        View in: PubMed
      46. Benedito R, Trindade A, Hirashima M, Henrique D, da Costa LL, Rossant J, Gill PS, Duarte A. Loss of Notch signalling induced by Dll4 causes arterial calibre reduction by increasing endothelial cell response to angiogenic stimuli. BMC Dev Biol. 2008; 8:117..
        View in: PubMed
      47. Scehnet JS, Ley EJ, Krasnoperov V, Liu R, Manchanda PK, Sjoberg E, Kostecke AP, Gupta S, Kumar SR, Gill PS. The role of Ephs, Ephrins, and growth factors in Kaposi sarcoma and implications of EphrinB2 blockade. Blood. 2009 Jan 1; 113(1):254-63..
        View in: PubMed
      48. Yavrouian EJ, Sinha UK, Rice DH, Salam MT, Gill PS, Masood R. The significance of EphB4 and EphrinB2 expression and survival in head and neck squamous cell carcinoma. Arch Otolaryngol Head Neck Surg. 2008 Sep; 134(9):985-91..
        View in: PubMed
      49. Trindade A, Kumar SR, Scehnet JS, Lopes-da-Costa L, Becker J, Jiang W, Liu R, Gill PS, Duarte A. Overexpression of delta-like 4 induces arterialization and attenuates vessel formation in developing mouse embryos. Blood. 2008 Sep 1; 112(5):1720-9..
        View in: PubMed
      50. Sanchez JJ, Børsting C, Balogh K, Berger B, Bogus M, Butler JM, Carracedo A, Court DS, Dixon LA, Filipovic B, Fondevila M, Gill P, Harrison CD, Hohoff C, Huel R, Ludes B, Parson W, Parsons TJ, Petkovski E, Phillips C, Schmitter H, Schneider PM, Vallone PM, Morling N. Forensic typing of autosomal SNPs with a 29 SNP-multiplex--results of a collaborative EDNAP exercise. Forensic Sci Int Genet. 2008 Jun; 2(3):176-83..
        View in: PubMed
      51. Cozen W, Gill PS, Salam MT, Nieters A, Masood R, Cockburn MG, Gauderman WJ, Martínez-Maza O, Nathwani BN, Pike MC, Van Den Berg DJ, Hamilton AS, Deapen DM, Mack TM. Interleukin-2, interleukin-12, and interferon-gamma levels and risk of young adult Hodgkin lymphoma. Blood. 2008 Apr 1; 111(7):3377-82..
        View in: PubMed
      52. Gunarathne A, Patel JV, Potluri R, Gill PS, Hughes EA, Lip GY. Secular trends in the cardiovascular risk profile and mortality of stroke admissions in an inner city, multiethnic population in the United Kingdom (1997-2005). J Hum Hypertens. 2008 Jan; 22(1):18-23..
        View in: PubMed
      53. Gill PS. The origin of Kaposi sarcoma. J Natl Cancer Inst. 2007 Jul 18; 99(14):1063..
        View in: PubMed
      54. Ku TK, Nguyen DC, Karaman M, Gill P, Hacia JG, Crowe DL. Loss of p53 expression correlates with metastatic phenotype and transcriptional profile in a new mouse model of head and neck cancer. Mol Cancer Res. 2007 Apr; 5(4):351-62..
        View in: PubMed
      55. Bishop KA, Stantchev TS, Hickey AC, Khetawat D, Bossart KN, Krasnoperov V, Gill P, Feng YR, Wang L, Eaton BT, Wang LF, Broder CC. Identification of Hendra virus G glycoprotein residues that are critical for receptor binding. J Virol. 2007 Jun; 81(11):5893-901..
        View in: PubMed
      56. Kumar SR, Masood R, Spannuth WA, Singh J, Scehnet J, Kleiber G, Jennings N, Deavers M, Krasnoperov V, Dubeau L, Weaver FA, Sood AK, Gill PS. The receptor tyrosine kinase EphB4 is overexpressed in ovarian cancer, provides survival signals and predicts poor outcome. Br J Cancer. 2007 Apr 10; 96(7):1083-91..
        View in: PubMed
      57. Scehnet JS, Jiang W, Kumar SR, Krasnoperov V, Trindade A, Benedito R, Djokovic D, Borges C, Ley EJ, Duarte A, Gill PS. Inhibition of Dll4-mediated signaling induces proliferation of immature vessels and results in poor tissue perfusion. Blood. 2007 Jun 1; 109(11):4753-60..
        View in: PubMed
      58. Damschroder MM, Widjaja L, Gill PS, Krasnoperov V, Jiang W, Dall'Acqua WF, Wu H. Framework shuffling of antibodies to reduce immunogenicity and manipulate functional and biophysical properties. Mol Immunol. 2007 Apr; 44(11):3049-60..
        View in: PubMed
      59. Sinha UK, Mazhar K, Chinn SB, Dhillon VK, Liu L, Masood R, Rice DH, Gill PS. The association between elevated EphB4 expression, smoking status, and advanced-stage disease in patients with head and neck squamous cell carcinoma. Arch Otolaryngol Head Neck Surg. 2006 Oct; 132(10):1053-9..
        View in: PubMed
      60. Masood R, Kumar SR, Sinha UK, Crowe DL, Krasnoperov V, Reddy RK, Zozulya S, Singh J, Xia G, Broek D, Schönthal AH, Gill PS. EphB4 provides survival advantage to squamous cell carcinoma of the head and neck. Int J Cancer. 2006 Sep 15; 119(6):1236-48..
        View in: PubMed
      61. Rasmi Y, Allameh A, Nasseri-Moghaddam S, Gill P, Moghaddam MF, Hedayati M. Comparison of glutathione S-transferase-Pi expression at mRNA levels in oesophageal mucosa using RT-PCR-ELISA in individuals with reflux diseases, adenocarcinoma and squamous cell carcinoma. Clin Biochem. 2006 Oct; 39(10):997-1001..
        View in: PubMed
      62. Gusmão L, Butler JM, Carracedo A, Gill P, Kayser M, Mayr WR, Morling N, Prinz M, Roewer L, Tyler-Smith C, Schneider PM. DNA Commission of the International Society of Forensic Genetics (ISFG): an update of the recommendations on the use of Y-STRs in forensic analysis. Int J Legal Med. 2006 Jul; 120(4):191-200..
        View in: PubMed
      63. Kumar SR, Singh J, Xia G, Krasnoperov V, Hassanieh L, Ley EJ, Scehnet J, Kumar NG, Hawes D, Press MF, Weaver FA, Gill PS. Receptor tyrosine kinase EphB4 is a survival factor in breast cancer. Am J Pathol. 2006 Jul; 169(1):279-93..
        View in: PubMed
      64. Gill P, Brenner CH, Buckleton JS, Carracedo A, Krawczak M, Mayr WR, Morling N, Prinz M, Schneider PM, Weir BS. DNA commission of the International Society of Forensic Genetics: Recommendations on the interpretation of mixtures. Forensic Sci Int. 2006 Jul 13; 160(2-3):90-101..
        View in: PubMed
      65. Xia G, Kumar SR, Hawes D, Cai J, Hassanieh L, Groshen S, Zhu S, Masood R, Quinn DI, Broek D, Stein JP, Gill PS. Expression and significance of vascular endothelial growth factor receptor 2 in bladder cancer. J Urol. 2006 Apr; 175(4):1245-52..
        View in: PubMed
      66. Gusmão L, Butler JM, Carracedo A, Gill P, Kayser M, Mayr WR, Morling N, Prinz M, Roewer L, Tyler-Smith C, Schneider PM. DNA Commission of the International Society of Forensic Genetics (ISFG): an update of the recommendations on the use of Y-STRs in forensic analysis. Forensic Sci Int. 2006 Mar 10; 157(2-3):187-97..
        View in: PubMed
      67. Levine AM, Tulpule A, Quinn DI, Gorospe G, Smith DL, Hornor L, Boswell WD, Espina BM, Groshen SG, Masood R, Gill PS. Phase I study of antisense oligonucleotide against vascular endothelial growth factor: decrease in plasma vascular endothelial growth factor with potential clinical efficacy. J Clin Oncol. 2006 Apr 10; 24(11):1712-9..
        View in: PubMed
      68. Xia G, Kumar SR, Stein JP, Singh J, Krasnoperov V, Zhu S, Hassanieh L, Smith DL, Buscarini M, Broek D, Quinn DI, Weaver FA, Gill PS. EphB4 receptor tyrosine kinase is expressed in bladder cancer and provides signals for cell survival. Oncogene. 2006 Feb 2; 25(5):769-80..
        View in: PubMed
      69. Dixon LA, Dobbins AE, Pulker HK, Butler JM, Vallone PM, Coble MD, Parson W, Berger B, Grubwieser P, Mogensen HS, Morling N, Nielsen K, Sanchez JJ, Petkovski E, Carracedo A, Sanchez-Diz P, Ramos-Luis E, Brion M, Irwin JA, Just RS, Loreille O, Parsons TJ, Syndercombe-Court D, Schmitter H, Stradmann-Bellinghausen B, Bender K, Gill P. Analysis of artificially degraded DNA using STRs and SNPs--results of a collaborative European (EDNAP) exercise. Forensic Sci Int. 2006 Dec 1; 164(1):33-44..
        View in: PubMed
      70. He S, Ding Y, Zhou J, Krasnoperov V, Zozulya S, Kumar SR, Ryan SJ, Gill PS, Hinton DR. Soluble EphB4 regulates choroidal endothelial cell function and inhibits laser-induced choroidal neovascularization. Invest Ophthalmol Vis Sci. 2005 Dec; 46(12):4772-9..
        View in: PubMed
      71. Kertesz N, Krasnoperov V, Reddy R, Leshanski L, Kumar SR, Zozulya S, Gill PS. The soluble extracellular domain of EphB4 (sEphB4) antagonizes EphB4-EphrinB2 interaction, modulates angiogenesis, and inhibits tumor growth. Blood. 2006 Mar 15; 107(6):2330-8..
        View in: PubMed
      72. Xia G, Kumar SR, Masood R, Koss M, Templeman C, Quinn D, Zhu S, Reddy R, Krasnoperov V, Gill PS. Up-regulation of EphB4 in mesothelioma and its biological significance. Clin Cancer Res. 2005 Jun 15; 11(12):4305-15..
        View in: PubMed
      73. Xia G, Kumar SR, Masood R, Zhu S, Reddy R, Krasnoperov V, Quinn DI, Henshall SM, Sutherland RL, Pinski JK, Daneshmand S, Buscarini M, Stein JP, Zhong C, Broek D, Roy-Burman P, Gill PS. EphB4 expression and biological significance in prostate cancer. Cancer Res. 2005 Jun 1; 65(11):4623-32..
        View in: PubMed
      74. Buscarini M, Quek ML, Gill P, Xia G, Quinn DI, Stein JP. Molecular prognostic factors in bladder cancer. BJU Int. 2005 Apr; 95(6):739-42..
        View in: PubMed
      75. Hotz HG, Hines OJ, Masood R, Hotz B, Foitzik T, Buhr HJ, Gill PS, Reber HA. VEGF antisense therapy inhibits tumor growth and improves survival in experimental pancreatic cancer. Surgery. 2005 Feb; 137(2):192-9..
        View in: PubMed
      76. Dixon LA, Murray CM, Archer EJ, Dobbins AE, Koumi P, Gill P. Validation of a 21-locus autosomal SNP multiplex for forensic identification purposes. Forensic Sci Int. 2005 Nov 10; 154(1):62-77..
        View in: PubMed
      77. Noy A, Scadden DT, Lee J, Dezube BJ, Aboulafia D, Tulpule A, Walmsley S, Gill P. Angiogenesis inhibitor IM862 is ineffective against AIDS-Kaposi's sarcoma in a phase III trial, but demonstrates sustained, potent effect of highly active antiretroviral therapy: from the AIDS Malignancy Consortium and IM862 Study Team. J Clin Oncol. 2005 Feb 10; 23(5):990-8..
        View in: PubMed
      78. Cozen W, Diaz-Sanchez D, James Gauderman W, Zadnick J, Cockburn MG, Gill PS, Masood R, Hamilton AS, Jyrala M, Mack TM. Th1 and Th2 cytokines and IgE levels in identical twins with varying levels of cigarette consumption. J Clin Immunol. 2004 Nov; 24(6):617-22..
        View in: PubMed
      79. Masood R, Xia G, Smith DL, Scalia P, Still JG, Tulpule A, Gill PS. Ephrin B2 expression in Kaposi sarcoma is induced by human herpesvirus type 8: phenotype switch from venous to arterial endothelium. Blood. 2005 Feb 1; 105(3):1310-8..
        View in: PubMed
      80. Frankel AE, Gill PS. VEGF and myeloid leukemias. Leuk Res. 2004 Jul; 28(7):675-7..
        View in: PubMed
      81. Wang JF, Liu ZY, Anand AR, Zhang X, Brown LF, Dezube BJ, Gill P, Ganju RK. Alpha-chemokine-mediated signal transduction in human Kaposi's sarcoma spindle cells. Biochim Biophys Acta. 2004 May 3; 1691(2-3):129-39..
        View in: PubMed
      82. Cozen W, Gill PS, Ingles SA, Masood R, Martínez-Maza O, Cockburn MG, Gauderman WJ, Pike MC, Bernstein L, Nathwani BN, Salam MT, Danley KL, Wang W, Gage J, Gundell-Miller S, Mack TM. IL-6 levels and genotype are associated with risk of young adult Hodgkin lymphoma. Blood. 2004 Apr 15; 103(8):3216-21..
        View in: PubMed
      83. Sinha UK, Kundra A, Scalia P, Smith DL, Parsa B, Masood R, Gill PS. Expression of EphB4 in head and neck squamous cell carcinoma. Ear Nose Throat J. 2003 Nov; 82(11):866, 869-70, 887..
        View in: PubMed
      84. Smith DL, Cai J, Zhu S, Wei W, Fukumoto J, Sharma S, Masood R, Gill PS. Natural killer cell cytolytic activity is necessary for in vivo antitumor activity of the dipeptide L-glutamyl-L-tryptophan. Int J Cancer. 2003 Sep 10; 106(4):528-33..
        View in: PubMed
      85. Masood R, Kundra A, Zhu S, Xia G, Scalia P, Smith DL, Gill PS. Malignant mesothelioma growth inhibition by agents that target the VEGF and VEGF-C autocrine loops. Int J Cancer. 2003 May 1; 104(5):603-10..
        View in: PubMed
      86. Bernstein ZP, Chanan-Khan A, Miller KC, Northfelt DW, Lopez-Berestein G, Gill PS. A multicenter phase II study of the intravenous administration of liposomal tretinoin in patients with acquired immunodeficiency syndrome-associated Kaposi's sarcoma. Cancer. 2002 Dec 15; 95(12):2555-61..
        View in: PubMed
      87. Tulpule A, Groopman J, Saville MW, Harrington W, Friedman-Kien A, Espina BM, Garces C, Mantelle L, Mettinger K, Scadden DT, Gill PS. Multicenter trial of low-dose paclitaxel in patients with advanced AIDS-related Kaposi sarcoma. Cancer. 2002 Jul 1; 95(1):147-54..
        View in: PubMed
      88. Hotz HG, Gill PS, Masood R, Hotz B, Buhr HJ, Foitzik T, Hines OJ, Reber HA. Specific targeting of tumor vasculature by diphtheria toxin-vascular endothelial growth factor fusion protein reduces angiogenesis and growth of pancreatic cancer. J Gastrointest Surg. 2002 Mar-Apr; 6(2):159-66; discussion 166..
        View in: PubMed
      89. Tulpule A, Sherrod A, Dharmapala D, Young LL, Espina BM, Sanchez MN, Gill PS, Levine AM. Multidrug resistance (MDR-1) expression in AIDS-related lymphomas. Leuk Res. 2002 Feb; 26(2):121-7..
        View in: PubMed
      90. Masood R, Cesarman E, Smith DL, Gill PS, Flore O. Human herpesvirus-8-transformed endothelial cells have functionally activated vascular endothelial growth factor/vascular endothelial growth factor receptor. Am J Pathol. 2002 Jan; 160(1):23-9..
        View in: PubMed
      91. Tully G, Bär W, Brinkmann B, Carracedo A, Gill P, Morling N, Parson W, Schneider P. Considerations by the European DNA profiling (EDNAP) group on the working practices, nomenclature and interpretation of mitochondrial DNA profiles. Forensic Sci Int. 2001 Dec 15; 124(1):83-91..
        View in: PubMed
      92. Gill P, Brenner C, Brinkmann B, Budowle B, Carracedo A, Jobling MA, de Knijff P, Kayser M, Krawczak M, Mayr WR, Morling N, Olaisen B, Pascali V, Prinz M, Roewer L, Schneider PM, Sajantila A, Tyler-Smith C. DNA Commission of the International Society of Forensic Genetics: recommendations on forensic analysis using Y-chromosome STRs. Forensic Sci Int. 2001 Dec 15; 124(1):5-10..
        View in: PubMed
      93. Masood R, Gordon EM, Whitley MD, Wu BW, Cannon P, Evans L, Anderson WF, Gill P, Hall FL. Retroviral vectors bearing IgG-binding motifs for antibody-mediated targeting of vascular endothelial growth factor receptors. Int J Mol Med. 2001 Oct; 8(4):335-43..
        View in: PubMed
      94. Masood R, Cai J, Zheng T, Smith DL, Hinton DR, Gill PS. Vascular endothelial growth factor (VEGF) is an autocrine growth factor for VEGF receptor-positive human tumors. Blood. 2001 Sep 15; 98(6):1904-13..
        View in: PubMed
      95. Masood R, Cai J, Tulpule A, Zheng T, Hamilton A, Sharma S, Espina BM, Smith DL, Gill PS. Interleukin 8 is an autocrine growth factor and a surrogate marker for Kaposi's sarcoma. Clin Cancer Res. 2001 Sep; 7(9):2693-702..
        View in: PubMed
      96. Carracedo A, Beckmann A, Bengs A, Brinkmann B, Caglia A, Capelli C, Gill P, Gusmão L, Hagelberg C, Hohoff C, Hoste B, Kihlgren A, Kloosterman A, Myhre Dupuy B, Morling N, O'Donnell G, Parson W, Phillips C, Pouwels M, Scheithauer R, Schmitter H, Schneider PM, Schumm J, Skitsa I, Stradmann-Bellinghausen B, Stuart M, Syndercombe Court D, Vide C. Results of a collaborative study of the EDNAP group regarding the reproducibility and robustness of the Y-chromosome STRs DYS19, DYS389 I and II, DYS390 and DYS393 in a PCR pentaplex format. Forensic Sci Int. 2001 Jun 1; 119(1):28-41..
        View in: PubMed
      97. Watson S, Allsop R, Foreman L, Kelsey Z, Gill P. Sequenced allelic ladders and population genetics of a new STR multiplex system. Forensic Sci Int. 2001 Jan 15; 115(3):207-17..
        View in: PubMed
      98. Gill P, Brenner C, Brinkmann B, Budowle B, Carracedo A, Jobling MA, de Knijff P, Kayser M, Krawczak M, Mayr WR, Morling N, Olaisen B, Pascali V, Prinz M, Roewer L, Schneider PM, Sajantila A, Tyler-Smith C. DNA commission of the International Society of Forensic Genetics: recommendations on forensic analysis using Y-chromosome STRs. Int J Legal Med. 2001; 114(6):305-9..
        View in: PubMed
      99. Levine AM, Seneviratne L, Espina BM, Wohl AR, Tulpule A, Nathwani BN, Gill PS. Evolving characteristics of AIDS-related lymphoma. Blood. 2000 Dec 15; 96(13):4084-90..
        View in: PubMed
      100. Masood R, Nagpal S, Zheng T, Cai J, Tulpule A, Smith DL, Gill PS. Kaposi sarcoma is a therapeutic target for vitamin D(3) receptor agonist. Blood. 2000 Nov 1; 96(9):3188-94..
        View in: PubMed
      101. Ablashi DV, Chatlynne L, Thomas D, Bourboulia D, Rettig MB, Vescio RA, Viza D, Gill P, Kyle RA, Berenson JR, Whitman JE. Lack of serologic association of human herpesvirus-8 (KSHV) in patients with monoclonal gammopathy of undetermined significance with and without progression to multiple myeloma. Blood. 2000 Sep 15; 96(6):2304-6..
        View in: PubMed
      102. Ferrario A, von Tiehl KF, Rucker N, Schwarz MA, Gill PS, Gomer CJ. Antiangiogenic treatment enhances photodynamic therapy responsiveness in a mouse mammary carcinoma. Cancer Res. 2000 Aug 1; 60(15):4066-9..
        View in: PubMed
      103. Hoffmann S, Masood R, Zhang Y, He S, Ryan SJ, Gill P, Hinton DR. Selective killing of RPE with a vascular endothelial growth factor chimeric toxin. Invest Ophthalmol Vis Sci. 2000 Jul; 41(8):2389-93..
        View in: PubMed
      104. Carracedo A, Bär W, Lincoln P, Mayr W, Morling N, Olaisen B, Schneider P, Budowle B, Brinkmann B, Gill P, Holland M, Tully G, Wilson M. DNA commission of the international society for forensic genetics: guidelines for mitochondrial DNA typing. Forensic Sci Int. 2000 May 15; 110(2):79-85..
        View in: PubMed
      105. Edelman DC, Ketema F, Saville RD, Herman J, Sill AM, Gill PS, Blattner WA, Constantine NT. Specifics on the refinement and application of two serological assays for the detection of antibodies to HHV-8. J Clin Virol. 2000 May; 16(3):225-37..
        View in: PubMed
      106. Munshi N, Groopman JE, Gill PS, Ganju RK. c-Src mediates mitogenic signals and associates with cytoskeletal proteins upon vascular endothelial growth factor stimulation in Kaposi's sarcoma cells. J Immunol. 2000 Feb 1; 164(3):1169-74..
        View in: PubMed
      107. Tulpule A, Scadden DT, Espina BM, Cabriales S, Howard W, Shea K, Gill PS. Results of a randomized study of IM862 nasal solution in the treatment of AIDS-related Kaposi's sarcoma. J Clin Oncol. 2000 Feb; 18(4):716-23..
        View in: PubMed
      108. Gill P, Sparkes R, Fereday L, Werrett DJ. Report of the European Network of Forensic Science Institutes (ENSFI): formulation and testing of principles to evaluate STR multiplexes. Forensic Sci Int. 2000 Jan 24; 108(1):1-29..
        View in: PubMed
      109. Moore JD, Dezube BJ, Gill P, Zhou XJ, Acosta EP, Sommadossi JP. Phase I dose escalation pharmacokinetics of O-(chloroacetylcarbamoyl) fumagillol (TNP-470) and its metabolites in AIDS patients with Kaposi's sarcoma. Cancer Chemother Pharmacol. 2000; 46(3):173-9..
        View in: PubMed
      110. Bär W, Brinkmann B, Budowle B, Carracedo A, Gill P, Holland M, Lincoln PJ, Mayr W, Morling N, Olaisen B, Schneider PM, Tully G, Wilson M. DNA Commission of the International Society for Forensic Genetics: guidelines for mitochondrial DNA typing. Int J Legal Med. 2000; 113(4):193-6..
        View in: PubMed
      111. Cai J, Zheng T, Masood R, Smith DL, Hinton DR, Kim CN, Fang G, Bhalla K, Gill PS. Paclitaxel Induces Apoptosis in AIDS-Related Kaposi's Sarcoma Cells. Sarcoma. 2000; 4(1-2):37-45..
        View in: PubMed
      112. Bär W, Brinkmann B, Budowle B, Carracedo A, Gill P, Holland M, Lincoln PJ, Mayr W, Morling N, Olaisen B, Schneider PM, Tully G, Wilson M. Guidelines for mitochondrial DNA typing. DNA Commission of the International Society for Forensic Genetics. Vox Sang. 2000; 79(2):121-5..
        View in: PubMed
      113. Lee RK, Cai JP, Deyev V, Gill PS, Cabral L, Wood C, Agarwal RP, Xia W, Boise LH, Podack E, Harrington WJ. Azidothymidine and interferon-alpha induce apoptosis in herpesvirus-associated lymphomas. Cancer Res. 1999 Nov 1; 59(21):5514-20..
        View in: PubMed
      114. Ablashi D, Chatlynne L, Cooper H, Thomas D, Yadav M, Norhanom AW, Chandana AK, Churdboonchart V, Kulpradist SA, Patnaik M, Liegmann K, Masood R, Reitz M, Cleghorn F, Manns A, Levine PH, Rabkin C, Biggar R, Jensen F, Gill P, Jack N, Edwards J, Whitman J, Boshoff C. Seroprevalence of human herpesvirus-8 (HHV-8) in countries of Southeast Asia compared to the USA, the Caribbean and Africa. Br J Cancer. 1999 Nov; 81(5):893-7..
        View in: PubMed
      115. Kundu RK, Sangiorgi F, Wu LY, Pattengale PK, Hinton DR, Gill PS, Maxson R. Expression of the human immunodeficiency virus-Tat gene in lymphoid tissues of transgenic mice is associated with B-cell lymphoma. Blood. 1999 Jul 1; 94(1):275-82..
        View in: PubMed
      116. Gill PS, Tulpule A, Espina BM, Cabriales S, Bresnahan J, Ilaw M, Louie S, Gustafson NF, Brown MA, Orcutt C, Winograd B, Scadden DT. Paclitaxel is safe and effective in the treatment of advanced AIDS-related Kaposi's sarcoma. J Clin Oncol. 1999 Jun; 17(6):1876-83..
        View in: PubMed
      117. Masood R, McGarvey ME, Zheng T, Cai J, Arora N, Smith DL, Sloane N, Gill PS. Antineoplastic urinary protein inhibits Kaposi's sarcoma and angiogenesis in vitro and in vivo. Blood. 1999 Feb 1; 93(3):1038-44..
        View in: PubMed
      118. Mihalcea AM, Smith DL, Monini P, Sgadari C, Ensoli B, Gill PS. Treatment update for AIDS-related Kaposi's sarcoma. AIDS. 1999; 13 Suppl A:S215-25..
        View in: PubMed
      119. Arora N, Masood R, Zheng T, Cai J, Smith DL, Gill PS. Vascular endothelial growth factor chimeric toxin is highly active against endothelial cells. Cancer Res. 1999 Jan 1; 59(1):183-8..
        View in: PubMed
      120. Gill P, d'Aloja E, Dupuy B, Eriksen B, Jangblad M, Johnsson V, Kloosterman AD, Kratzer A, Lareu MV, Mevag B, Morling N, Phillips C, Pfitzinger H, Rand S, Sabatier M, Scheithauer R, Schmitter H, Schneider P, Skitsa I, Vide MC. Report of the European DNA Profiling Group (EDNAP)--an investigation of the hypervariable STR loci ACTBP2, APOAI1 and D11S554 and the compound loci D12S391 and D1S1656. Forensic Sci Int. 1998 Dec 21; 98(3):193-200..
        View in: PubMed
      121. Tulpule A, Yung RC, Wernz J, Espina BM, Myers A, Scadden DT, Cabriales S, Ilaw M, Boswell W, Gill PS. Phase II trial of liposomal daunorubicin in the treatment of AIDS-related pulmonary Kaposi's sarcoma. J Clin Oncol. 1998 Oct; 16(10):3369-74..
        View in: PubMed
      122. Willis MC, Collins BD, Zhang T, Green LS, Sebesta DP, Bell C, Kellogg E, Gill SC, Magallanez A, Knauer S, Bendele RA, Gill PS, Janjic N, Collins B. Liposome-anchored vascular endothelial growth factor aptamers. Bioconjug Chem. 1998 Sep-Oct; 9(5):573-82..
        View in: PubMed
      123. McGarvey ME, Tulpule A, Cai J, Zheng T, Masood R, Espina B, Arora N, Smith DL, Gill PS. Emerging treatments for epidemic (AIDS-related) Kaposi's sarcoma. Curr Opin Oncol. 1998 Sep; 10(5):413-21..
        View in: PubMed
      124. Gill PS, Tsai YC, Rao AP, Spruck CH, Zheng T, Harrington WA, Cheung T, Nathwani B, Jones PA. Evidence for multiclonality in multicentric Kaposi's sarcoma. Proc Natl Acad Sci U S A. 1998 Jul 7; 95(14):8257-61..
        View in: PubMed
      125. Ganju RK, Munshi N, Nair BC, Liu ZY, Gill P, Groopman JE. Human immunodeficiency virus tat modulates the Flk-1/KDR receptor, mitogen-activated protein kinases, and components of focal adhesion in Kaposi's sarcoma cells. J Virol. 1998 Jul; 72(7):6131-7..
        View in: PubMed
      126. Chatlynne LG, Lapps W, Handy M, Huang YQ, Masood R, Hamilton AS, Said JW, Koeffler HP, Kaplan MH, Friedman-Kien A, Gill PS, Whitman JE, Ablashi DV. Detection and titration of human herpesvirus-8-specific antibodies in sera from blood donors, acquired immunodeficiency syndrome patients, and Kaposi's sarcoma patients using a whole virus enzyme-linked immunosorbent assay. Blood. 1998 Jul 1; 92(1):53-8..
        View in: PubMed
      127. Dezube BJ, Von Roenn JH, Holden-Wiltse J, Cheung TW, Remick SC, Cooley TP, Moore J, Sommadossi JP, Shriver SL, Suckow CW, Gill PS. Fumagillin analog in the treatment of Kaposi's sarcoma: a phase I AIDS Clinical Trial Group study. AIDS Clinical Trial Group No. 215 Team. J Clin Oncol. 1998 Apr; 16(4):1444-9..
        View in: PubMed
      128. Lunardi-Iskandar Y, Bryant JL, Blattner WA, Hung CL, Flamand L, Gill P, Hermans P, Birken S, Gallo RC. Effects of a urinary factor from women in early pregnancy on HIV-1, SIV and associated disease. Nat Med. 1998 Apr; 4(4):428-34..
        View in: PubMed
      129. Miles S, Levine A, Feldstein M, Carden J, Cabriallas S, Marcus S, Mitsuyasu R, Gill P. Open-label phase I study of combination therapy with zidovudine and interferon-beta in patients with AIDS-related Kaposi's sarcoma: AIDS Clinical Trials Group Protocol 057. Cytokines Cell Mol Ther. 1998 Mar; 4(1):17-23..
        View in: PubMed
      130. Cozen W, Masood R, Mack T, Gill PS, Ablashi DV. Seroprevalence of Kaposi's sarcoma-associated herpes virus antibody in young adult Hodgkin's disease. Blood. 1998 Jan 15; 91(2):724..
        View in: PubMed
      131. Olaisen B, Bär W, Brinkmann B, Budowle B, Carracedo A, Gill P, Lincoln P, Mayr WR, Rand S. DNA recommendations 1997 of the International Society for Forensic Genetics. Vox Sang. 1998; 74(1):61-3..
        View in: PubMed
      132. Cabriales S, Bresnahan J, Testa D, Espina BM, Scadden DT, Ross M, Gill PS. Extravasation of liposomal daunorubicin in patients with AIDS-associated Kaposi's sarcoma: a report of four cases. Oncol Nurs Forum. 1998 Jan-Feb; 25(1):67-70..
        View in: PubMed
      133. Hermans P, Clumeck N, Picard O, van Vooren JP, Duriez P, Zucman D, Bryant JL, Gill P, Lunardi-Iskandar Y, Gallo RC. AIDS-related Kaposi's sarcoma patients with visceral manifestations. Response to human chorionic gonadotropin preparations. J Hum Virol. 1998 Jan-Feb; 1(2):82-9..
        View in: PubMed
      134. Berlin A, Gill P, Stone R. Changes in PLAB examination will have implications for overseas doctors. BMJ. 1997 Dec 6; 315(7121):1539..
        View in: PubMed
      135. Gill PS, McLaughlin T, Espina BM, Tulpule A, Louie S, Lunardi-Iskandar Y, Gallo RC. Phase I study of human chorionic gonadotropin given subcutaneously to patients with acquired immunodeficiency syndrome-related mucocutaneous Kaposi's sarcoma. J Natl Cancer Inst. 1997 Dec 3; 89(23):1797-802..
        View in: PubMed
      136. Jie C, Tulpule A, Zheng T, Masood R, Espina B, Gill PS. Treatment of epidemic (AIDS-related) Kaposi's sarcoma. Curr Opin Oncol. 1997 Sep; 9(5):433-9..
        View in: PubMed
      137. Gill PS, Mitsuyasu RT, Montgomery T, Huang J, Cabriales S, Testa M, Espina BM, Levine AM, Miles SA. AIDS Clinical Trials Group Study 094: a phase I/II trial of ABV chemotherapy with zidovudine and recombinant human GM-CSF in AIDS-related Kaposi's sarcoma. Cancer J Sci Am. 1997 Sep-Oct; 3(5):278-83..
        View in: PubMed
      138. Bazarbachi A, Soriano V, Pawson R, Vallejo A, Moudgil T, Matutes E, Peries J, Molina A, de The H, Schulz TF, Catovsky D, Gill PS. Mycosis fungoides and Sezary syndrome are not associated with HTLV-I infection: an international study. Br J Haematol. 1997 Sep; 98(4):927-33..
        View in: PubMed
      139. Gill P, Tsai Y, Rao AP, Jones P. Clonality in Kaposi's sarcoma. N Engl J Med. 1997 Aug 21; 337(8):570-1; author reply 571-2..
        View in: PubMed
      140. Nagpal S, Cai J, Zheng T, Patel S, Masood R, Lin GY, Friant S, Johnson A, Smith DL, Chandraratna RA, Gill PS. Retinoid antagonism of NF-IL6: insight into the mechanism of antiproliferative effects of retinoids in Kaposi's sarcoma. Mol Cell Biol. 1997 Jul; 17(7):4159-68..
        View in: PubMed
      141. Gill P, Brinkmann B, d'Aloja E, Andersen J, Bar W, Carracedo A, Dupuy B, Eriksen B, Jangblad M, Johnsson V, Kloosterman AD, Lincoln P, Morling N, Rand S, Sabatier M, Scheithauer R, Schneider P, Vide MC. Considerations from the European DNA profiling group (EDNAP) concerning STR nomenclature. Forensic Sci Int. 1997 Jun 23; 87(3):185-92..
        View in: PubMed
      142. Husain SR, Gill P, Kreitman RJ, Pastan I, Puri RK. Interleukin-4 receptor expression on AIDS-associated Kaposi's sarcoma cells and their targeting by a chimeric protein comprised of circularly permuted interleukin-4 and Pseudomonas exotoxin. Mol Med. 1997 May; 3(5):327-38..
        View in: PubMed
      143. Gill P, d'Aloja E, Andersen J, Dupuy B, Jangblad M, Johnsson V, Kloosterman AD, Kratzer A, Lareu MV, Meldegaard M, Phillips C, Pfitzinger H, Rand S, Sabatier M, Scheithauer R, Schmitter H, Schneider P, Vide MC. Report of the European DNA profiling group (EDNAP): an investigation of the complex STR loci D21S11 and HUMFIBRA (FGA). Forensic Sci Int. 1997 Apr 18; 86(1-2):25-33..
        View in: PubMed
      144. Liu ZY, Ganju RK, Wang JF, Ona MA, Hatch WC, Zheng T, Avraham S, Gill P, Groopman JE. Cytokine signaling through the novel tyrosine kinase RAFTK in Kaposi's sarcoma cells. J Clin Invest. 1997 Apr 1; 99(7):1798-804..
        View in: PubMed
      145. Cai J, Zheng T, Lotz M, Zhang Y, Masood R, Gill P. Glucocorticoids induce Kaposi's sarcoma cell proliferation through the regulation of transforming growth factor-beta. Blood. 1997 Mar 1; 89(5):1491-500..
        View in: PubMed
      146. Masood R, Cai J, Zheng T, Smith DL, Naidu Y, Gill PS. Vascular endothelial growth factor/vascular permeability factor is an autocrine growth factor for AIDS-Kaposi sarcoma. Proc Natl Acad Sci U S A. 1997 Feb 4; 94(3):979-84..
        View in: PubMed
      147. Husain SR, Obiri NI, Gill P, Zheng T, Pastan I, Debinski W, Puri RK. Receptor for interleukin 13 on AIDS-associated Kaposi's sarcoma cells serves as a new target for a potent Pseudomonas exotoxin-based chimeric toxin protein. Clin Cancer Res. 1997 Feb; 3(2):151-6..
        View in: PubMed
      148. Bär W, Brinkmann B, Budowle B, Carracedo A, Gill P, Lincoln P, Mayr W, Olaisen B. DNA recommendations. Further report of the DNA Commission of the ISFH regarding the use of short tandem repeat systems. International Society for Forensic Haemogenetics. Int J Legal Med. 1997; 110(4):175-6..
        View in: PubMed
      149. Cai J, Zheng T, Murphy J, Waters CA, Lin GY, Gill PS. IL-4R expression in AIDS-KS cells and response to rhIL-4 and IL-4 toxin (DAB389-IL-4). Invest New Drugs. 1997; 15(4):279-87..
        View in: PubMed
      150. Tulpule A, Joshi B, DeGuzman N, Espina BM, Mocharnuk R, Prakash O, Templeton D, Levine AM, Gill PS. Interleukin-4 in the treatment of AIDS-related Kaposi's sarcoma. Ann Oncol. 1997 Jan; 8(1):79-83..
        View in: PubMed
      151. Varricchio F, Husain SR, Leland P, Gill P, Puri RK. Interleukin-4 receptor expression in vivo on human AIDS-related Kaposi's sarcoma. Oncol Res. 1997; 9(9):495-503..
        View in: PubMed
      152. Gill PS, Lunardi-Ishkandar Y, Louie S, Tulpule A, Zheng T, Espina BM, Besnier JM, Hermans P, Levine AM, Bryant JL, Gallo RC. The effects of preparations of human chorionic gonadotropin on AIDS-related Kaposi's sarcoma. N Engl J Med. 1996 Oct 24; 335(17):1261-9..
        View in: PubMed
      153. Krajden M, Zhao J, Bourke C, Scalia V, Gill P, Lau W. Detection of hepatitis C virus by PCR in second-generation enzyme immunoassay-seropositive blood donors by using matched pairs of fresh frozen plasma and pilot tube sera. J Clin Microbiol. 1996 Sep; 34(9):2191-5..
        View in: PubMed
      154. Mori N, Gill PS, Mougdil T, Murakami S, Eto S, Prager D. Interleukin-10 gene expression in adult T-cell leukemia. Blood. 1996 Aug 1; 88(3):1035-45..
        View in: PubMed
      155. Levine AM, Tulpule A, Espina B, Boswell W, Buckley J, Rasheed S, Stain S, Parker J, Nathwani B, Gill PS. Low dose methotrexate, bleomycin, doxorubicin, cyclophosphamide, vincristine, and dexamethasone with zalcitabine in patients with acquired immunodeficiency syndrome-related lymphoma. Effect on human immunodeficiency virus and serum interleukin-6 levels over time. Cancer. 1996 Aug 1; 78(3):517-26..
        View in: PubMed
      156. Gill PS, Wernz J, Scadden DT, Cohen P, Mukwaya GM, von Roenn JH, Jacobs M, Kempin S, Silverberg I, Gonzales G, Rarick MU, Myers AM, Shepherd F, Sawka C, Pike MC, Ross ME. Randomized phase III trial of liposomal daunorubicin versus doxorubicin, bleomycin, and vincristine in AIDS-related Kaposi's sarcoma. J Clin Oncol. 1996 Aug; 14(8):2353-64..
        View in: PubMed
      157. Collier DA, Arranz MJ, Sham P, Battersby S, Vallada H, Gill P, Aitchison KJ, Sodhi M, Li T, Roberts GW, Smith B, Morton J, Murray RM, Smith D, Kirov G. The serotonin transporter is a potential susceptibility factor for bipolar affective disorder. Neuroreport. 1996 Jul 8; 7(10):1675-9..
        View in: PubMed
      158. Broniscer A, Ribeiro RC, Srinivas RV, Behm FG, Head DR, Raimondi SC, Mandrell B, Gill P. An adolescent with HTLV-I-associated adult T cell leukemia treated with interferon-alfa and zidovudine. Leukemia. 1996 Jul; 10(7):1244-8..
        View in: PubMed
      159. Guo WX, Antakly T, Cadotte M, Kachra Z, Kunkel L, Masood R, Gill P. Expression and cytokine regulation of glucocorticoid receptors in Kaposi's sarcoma. Am J Pathol. 1996 Jun; 148(6):1999-2008..
        View in: PubMed
      160. Hu YW, Birch P, Balaskas E, Zeibdawi A, Scalia V, Thériault-Valin SA, Gill P, Aye MT. Flow cytometric immunofluorescence assay for detection of antibodies to human immunodeficiency virus type 1 using insoluble precursor forms of recombinant polyproteins as carriers and antigens. J Clin Microbiol. 1996 Jun; 34(6):1412-9..
        View in: PubMed
      161. Madigan MC, Sadun AA, Rao NS, Dugel PU, Tenhula WN, Gill PS. Tumor necrosis factor-alpha (TNF-alpha)-induced optic neuropathy in rabbits. Neurol Res. 1996 Apr; 18(2):176-84..
        View in: PubMed
      162. Formenti SC, Chak L, Gill P, Buess EM, Hill CK. Increased radiosensitivity of normal tissue fibroblasts in patients with acquired immunodeficiency syndrome (AIDS) and with Kaposi's sarcoma. Int J Radiat Biol. 1995 Oct; 68(4):411-2..
        View in: PubMed
      163. Lunardi-Iskandar Y, Gill P, Lam VH, Zeman RA, Michaels F, Mann DL, Reitz MS, Kaplan M, Berneman ZN, Carter D, et al. Isolation and characterization of an immortal neoplastic cell line (KS Y-1) from AIDS-associated Kaposi's sarcoma. J Natl Cancer Inst. 1995 Jul 5; 87(13):974-81..
        View in: PubMed
      164. Gill PS, Harrington W, Kaplan MH, Ribeiro RC, Bennett JM, Liebman HA, Bernstein-Singer M, Espina BM, Cabral L, Allen S, et al. Treatment of adult T-cell leukemia-lymphoma with a combination of interferon alfa and zidovudine. N Engl J Med. 1995 Jun 29; 332(26):1744-8..
        View in: PubMed
      165. Lunardi-Iskandar Y, Bryant JL, Zeman RA, Lam VH, Samaniego F, Besnier JM, Hermans P, Thierry AR, Gill P, Gallo RC. Tumorigenesis and metastasis of neoplastic Kaposi's sarcoma cell line in immunodeficient mice blocked by a human pregnancy hormone. Nature. 1995 May 4; 375(6526):64-8..
        View in: PubMed
      166. Harrington WJ, Ucar A, Gill P, Snodgrass S, Sheremata W, Cabral L, Rabin M, Byrne GE, Berger J, Voight W, et al. Clinical spectrum of HTLV-I in south Florida. J Acquir Immune Defic Syndr Hum Retrovirol. 1995 Apr 15; 8(5):466-73..
        View in: PubMed
      167. Louie S, Cai J, Law R, Lin G, Lunardi-Iskandar Y, Jung B, Masood R, Gill P. Effects of interleukin-1 and interleukin-1 receptor antagonist in AIDS-Kaposi's sarcoma. J Acquir Immune Defic Syndr Hum Retrovirol. 1995 Apr 15; 8(5):455-60..
        View in: PubMed
      168. Gill PS, Espina BM, Muggia F, Cabriales S, Tulpule A, Esplin JA, Liebman HA, Forssen E, Ross ME, Levine AM. Phase I/II clinical and pharmacokinetic evaluation of liposomal daunorubicin. J Clin Oncol. 1995 Apr; 13(4):996-1003..
        View in: PubMed
      169. Guo WX, Gill PS, Antakly T. Inhibition of AIDS-Kaposi's sarcoma cell proliferation following retinoic acid receptor activation. Cancer Res. 1995 Feb 15; 55(4):823-9..
        View in: PubMed
      170. Kimpton C, Gill P, D'Aloja E, Andersen JF, Bar W, Holgersson S, Jacobsen S, Johnsson V, Kloosterman AD, Lareu MV, et al. Report on the second EDNAP collaborative STR exercise. European DNA Profiling Group. Forensic Sci Int. 1995 Jan 30; 71(2):137-52..
        View in: PubMed
      171. Gill PS, Miles SA, Mitsuyasu RT, Montgomery T, McCarthy S, Espina BM, Feldstein M, Levine AM. Phase I AIDS Clinical Trials Group (075) study of adriamycin, bleomycin and vincristine chemotherapy with zidovudine in the treatment of AIDS-related Kaposi's sarcoma. AIDS. 1994 Dec; 8(12):1695-9..
        View in: PubMed
      172. Tak T, Rashtian M, De Tar M, Chandraratna PA, Gill P. An unusual case of metastatic intracardiac plasmacytoma. Can J Cardiol. 1994 Oct; 10(8):857-60..
        View in: PubMed
      173. Keung YK, Lau S, Gill P. Extramedullary plasmacytoma of the heart presenting as cardiac emergency. Review of literature. Am J Clin Oncol. 1994 Oct; 17(5):427-9..
        View in: PubMed
      174. Masood R, Lunardi-Iskandar Y, Jean LF, Murphy JR, Waters C, Gallo RC, Gill P. Inhibition of AIDS-associated Kaposi's sarcoma cell growth by DAB389-interleukin 6. AIDS Res Hum Retroviruses. 1994 Aug; 10(8):969-75..
        View in: PubMed
      175. Masood R, Lunardi-Iskandar Y, Moudgil T, Zhang Y, Law RE, Huang CL, Puri RK, Levine AM, Gill PS. IL-10 inhibits HIV-1 replication and is induced by tat. Biochem Biophys Res Commun. 1994 Jul 15; 202(1):374-83..
        View in: PubMed
      176. Cai J, Gill PS, Masood R, Chandrasoma P, Jung B, Law RE, Radka SF. Oncostatin-M is an autocrine growth factor in Kaposi's sarcoma. Am J Pathol. 1994 Jul; 145(1):74-9..
        View in: PubMed
      177. Kumar SR, Gill PS, Wagner DG, Dugel PU, Moudgil T, Rao NA. Human T-cell lymphotropic virus type I-associated retinal lymphoma. A clinicopathologic report. Arch Ophthalmol. 1994 Jul; 112(7):954-9..
        View in: PubMed
      178. Hamilton AS, Radka SF, Bernstein L, Gill PS, Gonsalves M, Naemura JR, Ross RK. Relationship of serum levels of oncostatin M to AIDS-related and classic Kaposi's sarcoma. J Acquir Immune Defic Syndr. 1994 Apr; 7(4):410-4..
        View in: PubMed
      179. Gill P, Kimpton C, D'Aloja E, Andersen JF, Bar W, Brinkmann B, Holgersson S, Johnsson V, Kloosterman AD, Lareu MV, et al. Report of the European DNA profiling group (EDNAP)--towards standardisation of short tandem repeat (STR) loci. Forensic Sci Int. 1994 Mar; 65(1):51-9..
        View in: PubMed
      180. Gill PS, Parkinson D. Solid tumor treatment workshop summary. Leukemia. 1994; 8 Suppl 3:S83-4..
        View in: PubMed
      181. Gill PS, Espina BM, Moudgil T, Kidane S, Esplin JA, Tulpule A, Levine AM. All-trans retinoic acid for the treatment of AIDS-related Kaposi's sarcoma: results of a pilot phase II study. Leukemia. 1994; 8 Suppl 3:S26-32..
        View in: PubMed
      182. Masood R, Cai J, Law R, Gill P. AIDS-associated Kaposi's sarcoma pathogenesis, clinical features, and treatment. Curr Opin Oncol. 1993 Sep; 5(5):831-4..
        View in: PubMed
      183. Masood R, Husain SR, Rahman A, Gill P. Potentiation of cytotoxicity of Kaposi's sarcoma related to immunodeficiency syndrome (AIDS) by liposome-encapsulated doxorubicin. AIDS Res Hum Retroviruses. 1993 Aug; 9(8):741-6..
        View in: PubMed
      184. Gill PS, Bernstein-Singer M, Espina BM, Rarick M, Magy F, Montgomery T, Berry MS, Levine A. Adriamycin, bleomycin and vincristine chemotherapy with recombinant granulocyte-macrophage colony-stimulating factor in the treatment of AIDS-related Kaposi's sarcoma. AIDS. 1992 Dec; 6(12):1477-81..
        View in: PubMed
      185. Dugel PU, Gill PS, Frangieh GT, Rao NA. Treatment of ocular adnexal Kaposi's sarcoma in acquired immune deficiency syndrome. Ophthalmology. 1992 Jul; 99(7):1127-32..
        View in: PubMed
      186. Ireland-Gill A, Espina BM, Akil B, Gill PS. Treatment of acquired immunodeficiency syndrome-related Kaposi's sarcoma using bleomycin-containing combination chemotherapy regimens. Semin Oncol. 1992 Apr; 19(2 Suppl 5):32-6; discussion 36-7..
        View in: PubMed
      187. Gill P, Woodroffe S, Bär W, Brinkmann B, Carracedo A, Eriksen B, Jones S, Kloosterman AD, Ludes B, Mevag B, et al. A report of an international collaborative experiment to demonstrate the uniformity obtainable using DNA profiling techniques. Forensic Sci Int. 1992 Feb; 53(1):29-43..
        View in: PubMed
      188. Weich HA, Salahuddin SZ, Gill P, Nakamura S, Gallo RC, Folkmann J. AIDS-associated Kaposi's sarcoma-derived cells in long-term culture express and synthesize smooth muscle alpha-actin. Am J Pathol. 1991 Dec; 139(6):1251-8..
        View in: PubMed
      189. Rarick MU, Montgomery T, Groshen S, Sullivan-Halley J, Jamin D, Mazumder A, Gill PS, Loureiro C, Levine AM. Intravenous immunoglobulin in the treatment of human immunodeficiency virus-related thrombocytopenia. Am J Hematol. 1991 Dec; 38(4):261-6..
        View in: PubMed
      190. Gill PS. Pathogenesis of HIV-related malignancies. Curr Opin Oncol. 1991 Oct; 3(5):867-71..
        View in: PubMed
      191. Gill PS. Phase I/II trials of alpha-interferon alone or in combination with zidovudine as maintenance therapy following induction chemotherapy in the treatment of acquired immunodeficiency syndrome-related Kaposi's sarcoma. Semin Oncol. 1991 Oct; 18(5 Suppl 7):53-7..
        View in: PubMed
      192. Zaharia L, Gill PS. Primary cardiac lymphoma. Am J Clin Oncol. 1991 Apr; 14(2):142-5..
        View in: PubMed
      193. Gill PS, Rarick M, McCutchan JA, Slater L, Parker B, Muchmore E, Bernstein-Singer M, Akil B, Espina BM, Krailo M, et al. Systemic treatment of AIDS-related Kaposi's sarcoma: results of a randomized trial. Am J Med. 1991 Apr; 90(4):427-33..
        View in: PubMed
      194. Hersh EM, Brewton G, Abrams D, Bartlett J, Galpin J, Gill P, Gorter R, Gottlieb M, Jonikas JJ, Landesman S, et al. Ditiocarb sodium (diethyldithiocarbamate) therapy in patients with symptomatic HIV infection and AIDS. A randomized, double-blind, placebo-controlled, multicenter study. JAMA. 1991 Mar 27; 265(12):1538-44..
        View in: PubMed
      195. Rarick MU, Loureiro C, Groshen S, Sullivan-Halley J, Gill PS, Bernstein-Singer M, Levine AM. Serum erythropoietin titers in patients with human immunodeficiency virus (HIV) infection and anemia. J Acquir Immune Defic Syndr. 1991; 4(6):593-7..
        View in: PubMed
      196. Bernard S, Gill P, Rosen P, Gavigan M, Steagall A, Ellingham E, Morgan T, Janic G, Ozer H. A phase I trial of alpha-interferon in combination with pentostatin in hematologic malignancies. Med Pediatr Oncol. 1991; 19(4):276-82..
        View in: PubMed
      197. Kumar R, Gill PS, Rattan PJ. Variations in plasma trace-elements concentration during fracture healing in dogs. Indian J Physiol Pharmacol. 1991 Jan; 35(1):58-60..
        View in: PubMed
      198. Gill PS, Naidu YM, Salahuddin SZ. Recent advances in AIDS-related Kaposi's sarcoma. Curr Opin Oncol. 1990 Dec; 2(6):1161-6..
        View in: PubMed
      199. Dugel PU, Gill PS, Frangieh GT, Rao NA. Ocular adnexal Kaposi's sarcoma in acquired immunodeficiency syndrome. Am J Ophthalmol. 1990 Nov 15; 110(5):500-3..
        View in: PubMed
      200. Gill PS, Rarick MU, Bernstein-Singer M, Espina BM, Jones B, Montgomery T, Sharma D, Rasheed S, Levine AM. Interferon-alpha maintenance therapy after cytotoxic chemotherapy for treatment of acquired immunodeficiency syndrome-related Kaposi's sarcoma. J Biol Response Mod. 1990 Oct; 9(5):512-6..
        View in: PubMed
      201. Laine L, Amerian J, Rarick M, Harb M, Gill PS. The response of symptomatic gastrointestinal Kaposi's sarcoma to chemotherapy: a prospective evaluation using an endoscopic method of disease quantification. Am J Gastroenterol. 1990 Aug; 85(8):959-61..
        View in: PubMed
      202. Gill P, Rarick M, Bernstein-Singer M, Harb M, Espina BM, Shaw V, Levine A. Treatment of advanced Kaposi's sarcoma using a combination of bleomycin and vincristine. Am J Clin Oncol. 1990 Aug; 13(4):315-9..
        View in: PubMed
      203. Dugel PU, Gill PS, Frangieh GT, Rasheed S, Rao NA. Particles resembling retrovirus and conjunctival Kaposi's sarcoma. Am J Ophthalmol. 1990 Jul 15; 110(1):86-7..
        View in: PubMed
      204. Gill PS, Rarick MU, Espina B, Loureiro C, Bernstein-Singer M, Akil B, Levine AM. Advanced acquired immune deficiency syndrome-related Kaposi's sarcoma. Results of pilot studies using combination chemotherapy. Cancer. 1990 Mar 1; 65(5):1074-8..
        View in: PubMed
      205. Rarick MU, Gill PS, Montgomery T, Bernstein-Singer M, Jones B, Levine AM. Treatment of epidemic Kaposi's sarcoma with combination chemotherapy (vincristine and bleomycin) and zidovudine. Ann Oncol. 1990; 1(2):147-9..
        View in: PubMed
      206. Shibata D, Brynes RK, Rabinowitz A, Hanson CA, Slovak ML, Spira TJ, Gill P. Human T-cell lymphotropic virus type I (HTLV-I)-associated adult T-cell leukemia-lymphoma in a patient infected with human immunodeficiency virus type 1 (HIV-1). Ann Intern Med. 1989 Dec 1; 111(11):871-5..
        View in: PubMed
      207. Gill PS, Brynes R. Recent advances in AIDS-related Kaposi's sarcoma. Curr Opin Oncol. 1989 Oct; 1(1):57-61..
        View in: PubMed
      208. Gill PS, Akil B, Colletti P, Rarick M, Loureiro C, Bernstein-Singer M, Krailo M, Levine AM. Pulmonary Kaposi's sarcoma: clinical findings and results of therapy. Am J Med. 1989 Jul; 87(1):57-61..
        View in: PubMed
      209. Gill PS, Loureiro C, Bernstein-Singer M, Rarick MU, Sattler F, Levine AM. Clinical effect of glucocorticoids on Kaposi sarcoma related to the acquired immunodeficiency syndrome (AIDS). Ann Intern Med. 1989 Jun 1; 110(11):937-40..
        View in: PubMed
      210. Formenti SC, Gill PS, Lean E, Rarick M, Meyer PR, Boswell W, Petrovich Z, Chak L, Levine AM. Primary central nervous system lymphoma in AIDS. Results of radiation therapy. Cancer. 1989 Mar 15; 63(6):1101-7..
        View in: PubMed
      211. Adams JS, Fernandez M, Gacad MA, Gill PS, Endres DB, Rasheed S, Singer FR. Vitamin D metabolite-mediated hypercalcemia and hypercalciuria patients with AIDS- and non-AIDS-associated lymphoma. Blood. 1989 Jan; 73(1):235-9..
        View in: PubMed
      212. Bertram JH, Snyder HW, Gill PS, Shulman I, Henry DH, Jenkins D, Kiprov DD. Protein A immunoadsorption therapy in HIV-related immune thrombocytopenia: a preliminary report. Artif Organs. 1988 Dec; 12(6):484-90..
        View in: PubMed
      213. Gardner LI, Dziados JE, Jones BH, Brundage JF, Harris JM, Sullivan R, Gill P. Prevention of lower extremity stress fractures: a controlled trial of a shock absorbent insole. Am J Public Health. 1988 Dec; 78(12):1563-7..
        View in: PubMed
      214. Jamin D, Shulman I, Lam HT, Aguilar S, Shields M, Cohen J, Gill P, Levine A. Production of a positive direct antiglobulin test due to suramin. Arch Pathol Lab Med. 1988 Sep; 112(9):898-900..
        View in: PubMed
      215. Loureiro C, Gill PS, Meyer PR, Rhodes R, Rarick MU, Levine AM. Autopsy findings in AIDS-related lymphoma. Cancer. 1988 Aug 15; 62(4):735-9..
        View in: PubMed
      216. Hu E, Hufford S, Lukes R, Bernstein-Singer M, Sobel G, Gill P, Pinter-Brown L, Rarick M, Rosen P, Brynes R, et al. Third-World Hodgkin's disease at Los Angeles County-University of Southern California Medical Center. J Clin Oncol. 1988 Aug; 6(8):1285-92..
        View in: PubMed
      217. Pollard DR, Gill P, Day A. The group-specific protein marker: a possible indicator of syphilis, not human immunodeficiency virus infection. CMAJ. 1988 Jun 1; 138(11):1013-5..
        View in: PubMed
      218. Chak LY, Gill PS, Levine AM, Meyer PR, Anselmo JA, Petrovich Z. Radiation therapy for acquired immunodeficiency syndrome-related Kaposi's sarcoma. J Clin Oncol. 1988 May; 6(5):863-7..
        View in: PubMed
      219. Gill PS, Valentine RJ, Oller DW, Rob CG. Intravagal paraganglioma: report of a case and a discussion of vascular parapharyngeal masses. Surgery. 1988 Apr; 103(4):432-7..
        View in: PubMed
      220. Gill PS, Levine AM. HIV-related malignant lymphoma: clinical aspects, treatment, and pathogenesis. Cancer Invest. 1988; 6(4):413-6..
        View in: PubMed
      221. Gill PS, Rarick M, Brynes RK, Causey D, Loureiro C, Levine AM. Azidothymidine associated with bone marrow failure in the acquired immunodeficiency syndrome (AIDS). Ann Intern Med. 1987 Oct; 107(4):502-5..
        View in: PubMed
      222. Loureiro C, Gill PS, Rarick M, Levine AM. Red hair and hyperpigmentation in a black man after chemotherapy. J Clin Oncol. 1987 Oct; 5(10):1705-6..
        View in: PubMed
      223. Cheson BD, Levine AM, Mildvan D, Kaplan LD, Wolfe P, Rios A, Groopman JE, Gill P, Volberding PA, Poiesz BJ, et al. Suramin therapy in AIDS and related disorders. Report of the US Suramin Working Group. JAMA. 1987 Sep 11; 258(10):1347-51..
        View in: PubMed
      224. Gill PS, Levine AM, Krailo M, Rarick MU, Loureiro C, Deyton L, Meyer P, Rasheed S. AIDS-related malignant lymphoma: results of prospective treatment trials. J Clin Oncol. 1987 Sep; 5(9):1322-8..
        View in: PubMed
      225. Turner RR, Levine AM, Gill PS, Parker JW, Meyer PR. Progressive histopathologic abnormalities in the persistent generalized lymphadenopathy syndrome. Am J Surg Pathol. 1987 Aug; 11(8):625-32..
        View in: PubMed
      226. Levine AM, Gill PS, Muggia F. Malignancies in the acquired immunodeficiency syndrome. Curr Probl Cancer. 1987 Jul-Aug; 11(4):209-55..
        View in: PubMed
      227. Turner RR, Meyer PR, Taylor CR, Gill PS, Hofman FM, Nichols P, Rasheed S, Levine AM. Immunohistology of persistent generalized lymphadenopathy. Evidence for progressive lymph node abnormalities in some patients. Am J Clin Pathol. 1987 Jul; 88(1):10-9..
        View in: PubMed
      228. Laine L, Politoske EJ, Gill P. Protein-losing enteropathy in acquired immunodeficiency syndrome due to intestinal Kaposi's sarcoma. Arch Intern Med. 1987 Jun; 147(6):1174-5..
        View in: PubMed
      229. Levine AM, Gill PS. AIDS-related malignant lymphoma: clinical presentation and treatment approaches. Oncology (Williston Park). 1987 Jun; 1(4):41-6..
        View in: PubMed
      230. Burkes RL, Abo W, Levine AM, Linker-Israeli M, Parker JW, Gill PS, Krailo M, Horwitz DA. Characterization of immunologic function in homosexual men with persistent, generalized lymphadenopathy and acquired immune deficiency syndrome. Cancer. 1987 Feb 15; 59(4):731-8..
        View in: PubMed
      231. Gill PS, Chandraratna PA, Meyer PR, Levine AM. Malignant lymphoma: cardiac involvement at initial presentation. J Clin Oncol. 1987 Feb; 5(2):216-24..
        View in: PubMed
      232. O'Donnell MR, Forman SJ, Levine AM, Territo M, Farbstein MJ, Fahey JL, Gill P, Lazar G, Nademanee A, Neely S, et al. Cytarabine, cisplatin, and etoposide chemotherapy for refractory non-Hodgkin's lymphoma. Cancer Treat Rep. 1987 Feb; 71(2):187-9..
        View in: PubMed
      233. Bertram JH, Gill PS, Levine AM, Boquiren D, Hoffman FM, Meyer P, Mitchell MS. Monoclonal antibody T101 in T cell malignancies: a clinical, pharmacokinetic, and immunologic correlation. Blood. 1986 Sep; 68(3):752-61..
        View in: PubMed
      234. Gill PS, Levine AM, Meyer PR, Aguilar SL, Rarick M, Parker JW, Rasheed S. Human T-cell lymphotropic virus type III associated disorders. The spectrum in the heterosexual population. Arch Intern Med. 1986 Aug; 146(8):1501-4..
        View in: PubMed
      235. Levine AM, Gill PS, Cohen J, Hawkins JG, Formenti SC, Aguilar S, Meyer PR, Krailo M, Parker J, Rasheed S. Suramin antiviral therapy in the acquired immunodeficiency syndrome. Clinical, immunological, and virologic results. Ann Intern Med. 1986 Jul; 105(1):32-7..
        View in: PubMed
      236. Burkes RL, Sherrod AE, Stewart ML, Gill PS, Aguilar S, Taylor CR, Krailo MD, Levine AM. Serum beta-2 microglobulin levels in homosexual men with AIDS and with persistent, generalized lymphadenopathy. Cancer. 1986 Jun 1; 57(11):2190-2..
        View in: PubMed
      237. Burkes RL, Meyer PR, Gill PS, Parker JW, Rasheed S, Levine AM. Rectal lymphoma in homosexual men. Arch Intern Med. 1986 May; 146(5):913-5..
        View in: PubMed
      238. Gill PS, Meyer PR, Pavlova Z, Levine AM. B cell acute lymphocytic leukemia in adults. Clinical, morphologic, and immunologic findings. J Clin Oncol. 1986 May; 4(5):737-43..
        View in: PubMed
      239. Rasheed S, Norman GL, Gill PS, Meyer PR, Cheng L, Levine AM. Virus-neutralizing activity, serologic heterogeneity, and retrovirus isolation from homosexual men in the Los Angeles area. Virology. 1986 Apr 15; 150(1):1-9..
        View in: PubMed
      240. Levine AM, Meyer PR, Gill PS, Burkes RL, Krailo M, Aguilar S, Parker JW. Results of initial lymph node biopsy in homosexual men with generalized lymphadenopathy. J Clin Oncol. 1986 Feb; 4(2):165-9..
        View in: PubMed
      241. Levine AM, Gill PS, Rasheed S. Human retrovirus-associated lymphoproliferative disorders in homosexual men. Prog Allergy. 1986; 37:244-58..
        View in: PubMed
      242. Gill PS, Graham RA, Boswell W, Meyer P, Krailo M, Levine AM. A comparison of imaging, clinical, and pathologic aspects of space-occupying lesions within the brain in patients with acquired immune deficiency syndrome. Am J Physiol Imaging. 1986; 1(3):134-41..
        View in: PubMed
      243. Levine AM, Gill PS, Meyer PR, Burkes RL, Ross R, Dworsky RD, Krailo M, Parker JW, Lukes RJ, Rasheed S. Retrovirus and malignant lymphoma in homosexual men. JAMA. 1985 Oct 11; 254(14):1921-5..
        View in: PubMed
      244. Burkes RL, Gal AA, Stewart ML, Gill PS, Abo W, Levine AM. Simultaneous occurrence of Pneumocystis carinii pneumonia, cytomegalovirus infection, Kaposi's sarcoma, and B-immunoblastic sarcoma in a homosexual man. JAMA. 1985 Jun 21; 253(23):3425-8..
        View in: PubMed
      245. Gill PS, Levine AM, Meyer PR, Boswell WD, Burkes RL, Parker JW, Hofman FM, Dworsky RL, Lukes RJ. Primary central nervous system lymphoma in homosexual men. Clinical, immunologic, and pathologic features. Am J Med. 1985 May; 78(5):742-8..
        View in: PubMed
      246. Levine AM, Burkes RL, Walker M, Meyer PR, Gill PS, Nichols PW, Dworsky R, Parker JW, Lukes RJ. B-cell lymphoma in two monogamous homosexual men. Arch Intern Med. 1985 Mar; 145(3):479-81..
        View in: PubMed
      247. Nicholls ES, Chaudhary RK, Kennedy DA, Jung J, Davies JW, Gill P. Hepatitis B follow-up among Indochinese refugees. Can Med Assoc J. 1984 Nov 1; 131(9):1073-6..
        View in: PubMed
      248. Ziegler JL, Beckstead JA, Volberding PA, Abrams DI, Levine AM, Lukes RJ, Gill PS, Burkes RL, Meyer PR, Metroka CE, et al. Non-Hodgkin's lymphoma in 90 homosexual men. Relation to generalized lymphadenopathy and the acquired immunodeficiency syndrome. N Engl J Med. 1984 Aug 30; 311(9):565-70..
        View in: PubMed
      249. Siboo R, Gill P, Burke B. Characterization of L5178Y leukemic cells by phagocytosis, cytochemical methods, and membrane marker techniques. Cancer Res. 1977 Oct; 37(10):3607-11..
        View in: PubMed
      Parkash's Networks
      Related Concepts
      Derived automatically from this person's publications.
      _
      Co-Authors at USC
      People in Profiles who have published with this person.
      _
      Related Authors at USC
      People who share related concepts with this person.
      _
      Same Department
      Back to TOP